中文简介:Tina Wong 教授是新加坡国家眼科中心青光眼科高级顾问医师及前主任,现任杜克-新加坡国立大学医学院眼科学教师与职业发展副主席,同时担任新加坡眼科研究所临床转化研究主任及眼部治疗与药物递送研究组共同负责人。她长期专注于眼部瘢痕形成、青光眼术后管理、眼科新型治疗药物开发、药物再利用及持续药物递送系统研究,致力于提高患者依从性并改善青光眼手术结局。Wong 教授已开发 2 项进入 II 期临床试验的持续药物递送治疗技术,拥有 10 项专利,并共同创立 3 家由其研究成果转化而来的生物技术公司。她曾获得新加坡总统科学与技术奖等重要荣誉,并入选 The Ophthalmologist Power List 及 Asia Pacific Eye 100,是国际青光眼和眼部药物递送领域具有重要影响力的专家。
英文简介:Professor Tina Wong is a Senior Consultant and Immediate Past Head of the Glaucoma Service at the Singapore National Eye Centre. She is also Vice Chair in Faculty and Professional Development for Ophthalmology at Duke-NUS Medical School, Director of Clinical Translational Research, and Co-Head of the Ocular Therapeutics and Drug Delivery Group at the Singapore Eye Research Institute. Professor Wong has a specialist interest in ocular scarring and post-glaucoma surgery management. She leads an interdisciplinary translational and clinical research programme focused on developing new therapeutics, drug repurposing, and sustained drug delivery systems to improve patient adherence and surgical outcomes. She has developed two sustained drug delivery therapies that have reached Phase II clinical trials for glaucoma and cataract surgery, holds 10 patents, and is a co-founder of three spin-off biotechnology companies. Professor Wong has received national and international awards for her contributions to glaucoma wound healing and ocular therapeutic delivery, including Singapore’s President’s Science and Technology Award. She is recognized as a scientific thought leader in glaucoma surgery wound healing and sustained ocular therapeutics delivery, and has been listed in The Ophthalmologist Power List and Asia Pacific Eye 100.
11
0
0
| 日期 | 时间 | 会场 | Session | 角色 | 讲题 |
|---|---|---|---|---|---|
| 2026-05-29 | 16:15-16:30 | 分会场9(二层,N215会议室) |
中国-新加坡眼科临床新进展会议 |
讲者 | 结膜炎症性疾病对青光眼滤过手术结局的影响 |